| Yale Ventures

Collab CT

Collaborative CT: 2025 Kick-Off

4:30PM—6:30PM

yale innovations

From the Managing Director: Progress and Possibility

Evershield: Long-acting, biodegradable implants for local, sustained drug release

Ranjit

B3 Therapeutics: Bypassing the blood brain barrier for the treatment of primary CNS tumors and brain metastases

Grutzendler Head Shot

Brain Endothelium-Targeted Therapy for Cerebral Cavernous Malformations

Seth Herzon

DNA Self-Activating Warheads (SAWs)

Jose

Targeting Non-Tuberculous Mycobacteria with AI-Designed Antimicrobial Peptides

Ho-Joon

EDDIT: Early Drug Discovery for Targeted Protein Degradation

Waxman

ChondroNEXT will prevent progression of Osteoarthritis by preventing joint degeneration.

Bunick Head Shot

Novel treatment for hypertrophic and keloidal scarring

Subscribe to